Skip to main content

Table 2 Changes from M0 to M24 in plasma markers of inflammation and immune activation (log e -transformed values)

From: Comparative impact of antiretroviral drugs on markers of inflammation and immune activation during the first two years of effective therapy for HIV-1 infection: an observational study

  

Total n = 78

TDF/ FTC n = 61

ABC/ 3TC n = 17

EFV n = 36

ATV/r n = 27

LPV/r n = 15

IL-6

Baseline (pg/ml)

1.6 (1.1-2.5)

1.6 (1.1-2.6)

1.2 (0.99-1.7)

1.6 (1.1-2.5)

1.2 (0.88-2.4)

2.17 (1.1-7.4)

Mean fold change (95% CI)

0.60 (0.49, 0.74)

0.60 (0.48, 0.77)

0.60 (0.36, 0.99)

0.59 (0.42, 0.83)

0.82 (0.64, 1.05)

0.36 (0.20, 0.67)

P value*

<0.001

     

hs-CRP

Baseline (mg/L)

4 (2.2-15)

4.2 (2.3-15)

2.7 (1.8-9.4)

3.9 (2.2-17.8)

3 (2-5.9)

7.5 (2.9-20)

Mean fold change (95% CI)

0.77 (0.57, 1.1)

0.81 (0.56, 1.20)

0.66 (0.33, 1.30)

0.76 (0.46, 1.26)

0.88 (0.54, 1.44)

0.63 (0.27, 1.47)

P value

0.11

     

sCD14

Baseline (106 pg/ml)

2.6 (2.1-3.1)

2.6 (2.2-3.1)

2.5 (2-3.1)

2.5 (2.2-3)

2.6 (1.7-3.1)

3.1 (2-3.4)

Mean fold change (95% CI)

1.00 (0.93, 1.1)

1.00 (0.93, 1.10)

0.96 (0.79, 1.15)

0.95 (0.85, 1.06)

1.10 (0.93, 1.26)

1.00 (0.85, 1.20)

P value

0.82

     

IP-10

Baseline (pg/ml)

664 (431-960)

630 (435-974)

721 (431-895)

692 (447-996)

549 (389-781)

798 (470-1326)

Mean fold change (95% CI)

0.41 (0.35, 0.49)

0.44 (0.36, 0.52)

0.37 (0.27, 0.49)

0.34 (0.28, 0.42)

0.53 (0.40, 0.71)

0.43 (0.27, 0.67)

P value

<0.001

     

MIG

Baseline (pg/ml)

1532 (980-2804)

1534 (1004-2804)

1431 (938-2562)

1908 (1093-3799)

1182 (920-2201)

1611 (887-2444)

Mean fold change (95% CI)

0.26 (0.19, 0.33)

0.25 (0.18, 0.35)

0.27 (0.17, 0.42)

0.16 (0.10, 0.24)

0.39 (0.30, 0.51)

0.39 (0.22, 0.70)

 

P value

<0.001

     
  1. TDF, Tenofovir; FTC, Emtricitabine; ABC, Abacavir; 3TC, Lamivudine; EFV, Efavirenz; ATV/r, Atazanavir/ritonavir; LPV/r, Lopinavir/ritonavir; IL-6, Interleukin-6; hs-CRP, Highly sensitive C-reactive protein; sCD14, soluble CD14; 1P10, Interferon-γ-Inducible Protein 10; MIG, Monokine induced by interferon-γ; CI, Confidence Interval.
  2. *One-sample Student’s t test of the change of each marker in the overall study sample.